COMPASS Pathways plc
CMPSNASDAQHealthcareMedical Care Facilities
As of Oct 16, 2026 close
- Market cap
- $1.57B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $4.88$15.87
- Volume (live)
- -
- Avg. volume (3M)
- 2.93M
COMPASS Pathways (CMPS) Stock Price & Financial Analysis
COMPASS Pathways Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $10.72 - $11.60 |
|---|---|
| 52-Week High | $15.87 |
| 52-Week Low | $4.88 |
| Open | $11.51 |
| Volume (last close) | 4.97M |
| Average Volume (3M) | 2.93M |
| 50-Day MA | $13.40 |
|---|---|
| 200-Day MA | $10.13 |
| 1-Year Change | +78.22% |
| Market Cap | 1.57B |
|---|---|
| Shares Outstanding | 135.04M |
| Price to Book (P/B) | 18.56 |
| EV/EBITDA | -3.03 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
COMPASS Pathways at a Glance
As of the Oct 16, 2026 close, COMPASS Pathways (CMPS) has a market capitalization of $1.57B.
As of its latest reported balance sheet, it holds $433.30M in cash and securities against $52.61M of debt, a net cash position of $380.68M.
COMPASS Pathways does not currently pay a dividend.
The share price is up 78.2% over the past year. At $10.75 (the Oct 16, 2026 close) it sits within its 52-week range of $4.88 to $15.87, above its 200-day moving average of $10.13.
Based on 11 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $24.91, 131.7% above the Oct 16, 2026 close.
Frequently Asked Questions About COMPASS Pathways
What is the current stock price for CMPS?
As of the Oct 16, 2026 close, CMPS stock trades at $10.75. The 52-week range is $4.88–$15.87, with a day range of $10.72–$11.60.
What is the P/E ratio for CMPS?
The P/E ratio (Price-to-Earnings) for CMPS is shown in the Key Statistics section. This valuation metric helps compare COMPASS Pathways plc to industry peers.
Does CMPS pay dividends?
COMPASS Pathways does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CMPS?
Based on ratings from 11 professional analysts over the last 90 days, the consensus for CMPS is Buy. The average 12-month price target is $24.91, a 131.7% upside from the Oct 16, 2026 close of $10.75.
What is the market cap of CMPS?
As of the Oct 16, 2026 close, COMPASS Pathways's market capitalization is $1.45B, classifying it as a small-cap company. COMPASS Pathways operates in the Healthcare sector within the Medical Care Facilities industry.